Physician profile
Roya M Qaemi
NPI 1881849784
$2,239.78
in general payments reported to CMS, 2019-2025
38 companies · $378 in 2025
The $378 reported for 2025 was more than what 87% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $192 · 2021: $175 · 2022: $312 · 2023: $517 · 2024: $469 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,364.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,364.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $347.44 | 2019-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $282.82 | 2022-2025 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $240.00 | 2020-2025 | Farxiga, Andexxa |
| Paratek Pharmaceuticals, INC. | $149.88 | 2023-2024 | Nuzyra |
| Novartis Pharmaceuticals Corporation | $127.99 | 2022-2024 | |
| Novo Nordisk INC | $98.71 | 2020-2024 | Ozempic, Rybelsus |
| Vifor Pharma, INC. | $72.81 | 2019-2021 | |
| Madrigal Pharmaceuticals | $64.23 | 2025 | Rezdiffra |
| Stryker Corporation | $61.13 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Gilead Sciences, INC. | $60.69 | 2022-2024 | |
| Janssen Scientific Affairs, LLC | $58.37 | 2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $47.19 | 2021-2023 | Lifevest |
| Vertex Pharmaceuticals Incorporated | $39.91 | 2024-2025 | |
| Ferring Pharmaceuticals INC. | $39.77 | 2022 | |
| Chiesi USA, INC. | $39.32 | 2022 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roya Qaemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.